APA (7th ed.) Citation

Lin, D., Morrison, L., Pilon, D., Benson, C., Ghelerter, I., Vermette-Laforme, M., & Lefebvre, P. (2021). PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate. Value in Health, 24, S129. https://doi.org/10.1016/j.jval.2021.04.630

Chicago Style (17th ed.) Citation

Lin, D., L. Morrison, D. Pilon, C. Benson, I. Ghelerter, M. Vermette-Laforme, and P. Lefebvre. "PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate." Value in Health 24 (2021): S129. https://doi.org/10.1016/j.jval.2021.04.630.

MLA (9th ed.) Citation

Lin, D., et al. "PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate." Value in Health, vol. 24, 2021, p. S129, https://doi.org/10.1016/j.jval.2021.04.630.